of 2,3-disubstituted indoles through the coupling of
R-diazoketones with 2-aminoaryl ketones while the coupling
of R-diazoketones with β-enaminoketones or esters affords
the corresponding 2,4,5-trisubstituted pyrroles in good yields.
Initially, we attempted the coupling of aryl diazoketone
with 2-aminoaryl ketone in the presence of 10 mol % of
Cu(OTf)2. Although the reaction proceeds smoothly at
25 °C, it required a prolonged reaction time (12 h) to
achieve high conversion. But the rate of reaction was
enhanced remarkably by increasing the temperature from
25 to 80 °C. For instance, treatment of phenyldiazoketone
(1a) with 2-aminoacetophenone (2a) in the presence of
10 mol % Cu(OTf)2 in DCE at 80 °C over 2 h afforded the
corresponding 3-methyl-2-benzoylindole 3a in 90% yield.
Inspired by the above result, we turned our attention toward
investigating the scope of this methodology. To our delight,
various aryl diazoketones reacted well with 2-aminoaryl
Figure 1. Biologically active indole based molecules.
Table 1. Synthesis of Indoles from R-Diazoketones with
2-Aminoalkyl or arylketones
construction of several indole based heterocycles.9 Further-
more, a 4-oxo-4,5,6,7-tetrahydroindole core is often pre-
sent in many biologically important alkaloids such as
mitomycins and 7-methoxymitosene.10 Consequently, a
three-component process has been developed for the
synthesis of annulated pyrroles through the condensation
of R-haloketones with 1,3-cyclohexadiones and ammonia
or primary amines.11 More recently, an elegant approach
has been devised for the synthesis of annulated pyrroles
from the MoritaÀ BaylisÀHillman acetates which in turn
are derived from the 2-oxo-2-(phenyl)acetaldehyde and
cyclohexenone.12 We also explored the synthetic potential
of R-diazoketones for the synthesis of biologically active
heterocycles such as imidazo[1,2-a]pyridines, 2-aminothio-
zoles, quinoxalines, spirooxindoles, and cyclopropyl glycals.13
Here, wewish toreportanefficientmethodforthesynthesis
(9) (a) Matsumoto, M.; Ishida, Y.; Watanabe, N. Heterocycles 1985,
23, 165. (b) Matsumoto, M.; Ishida, Y.; Hatanaka, N. Heterocycles
1986, 24, 1667. (c) Hatanaka, N.; Ozaki, O.; Matsumoto, M. Tetrahe-
dron Lett. 1986, 27, 3169. (d) Matsumoto, M.; Watanabe, N. Hetero-
cycles 1986, 24, 3149. (e) Ishibashi, H.; Tabata, T.; Hanaoka, K.;
Iriyama, H.; Akamasu, S.; Ikeda, M. Tetrahedron Lett. 1993, 34, 489.
(f) Ishibashi, H.; Akamatsu, S.; Iriyama, H.; Hanaoka, K.; Tabata, T.;
Ikeda, M. Chem. Pharm. Bull. 1994, 42, 271. (g) Doi, K.; Mori, M.
Heterocycles 1996, 42, 113. (h) Edstrom, E.; Yu, T. Tetrahedron 1997, 53,
4549. (i) Martinez, R.; Oloarte, J.; Avila, G. J. Heterocycl. Chem. 1998,
35, 585. (j) Hayakawa, I.; Shioya, R.; Agatsuma, T.; Furukawa, H.;
Naruto, S.; Sugano, Y. Bioorg. Med. Chem. Lett. 2004, 14, 4383. (k)
Davies, H. M. L.; Manning, J. R. J. Am. Chem. Soc. 2006, 128, 1060. (l)
Arai, M.; Ishikawa, T.; Saito, S.; Miyauchi, Y.; Miyahara, T. Synlett
2009, 122.
(10) (a) Nakajima, S.; Yoshida, K.; Mon, M.; Ban, Y.; Shibasaki, M.
Chem. Commun. 1990, 468. (b) Galm, U.; Hager, M. H.; Lanen, S. G. V.;
Ju, J.; Thorson, J. S.; Shen, B. Chem. Rev. 2005, 105, 739. (c) Jolles, B.;
Laigle, A. Chem.-Biol. Interact. 1995, 94, 215. (d) Fiallo, M. M. L.;
Kozlowski, H.; Suillerot, A. G. Eur. J. Pharmaceut. Sci. 2001, 12, 487. (e)
Na, Y.; Wang, S.; Kohn, H. J. Am. Chem. Soc. 2002, 124, 4666. (f) Allen,
G. R.; Poletto, J. F.; Weiss, M. J. J. Am. Chem. Soc. 1964, 86, 3877.
(11) Stetter, H.; Lauterbach, R. J. Liebigs Ann. Chem. 1962, 655, 20.
(12) Batchu, H.; Batra, S. Eur. J. Org. Chem. 2012, 2935.
(13) (a) Reddy, B. V. S.; Karthik, G.; Rajasekaran, T.; Antony, A.;
Sridhar, B. Tetrahedron Lett. 2012, 53, 2396. (b) Reddy, B. V. S.;
Rajasekaran, T.; Karthik, G.; Rao, T. P. Tetrahedron Lett. 2012, 53,
3416. (c) Yadav, J. S.; Reddy, B. V. S.; Rao, Y. G.; Narsaiah, A. V.
Tetrahedron Lett. 2008, 49, 2381.
a All tie products were characterized by NMR, IR and mass spectros-
copy. b Yield refers to pure product after chromatography.
Org. Lett., Vol. 15, No. 3, 2013
465